Jiro Okochi (Chief Executive Officer, Co-founder) Jiro Okochi is responsible for
setting and executing the vision for Reval as the leading provider of financial
risk management technology solutions and services. He has more than twenty years
of experience in financial markets and management at Security Pacific, DKB,
Deutsche Bank and Westdeutsche Landesbank. Prior to starting Reval in 1999, he
was the head of derivatives sales at WestLB in New York. In 2003, Okochi was
selected as one of the 100 Most Influential People in Finance by Treasury and
Risk Management magazine. He is a frequent presenter at trade conferences,
including The Association of Finance Professionals, Eurofinance, Treasury &
Risk Management, Financial Executives International, Deloitte & Touche
events and at Kase & Company. Okochi holds a bachelor's of science degree in
genetics from the University of California at Berkeley. Woo Song (Chief
Technology Officer, Co-founder) With more than fifteen years of experience with
mission-critical trading systems, Woo Song oversees Reval's leading software and
delivery architecture. As a technology expert who is also a former derivatives
trader, he brings a unique perspective on the use of technology to enhance
trading and risk management activities. Song is also Co-founder and Chairman of
Intrasphere Technologies, Inc., a leading mid-size IT services firm located in
New York City. In recognition of his achievements, he was named an Ernst &
Young Entrepreneur of the Year in 2001. He currently serves on a number of
non-profit boards, including the New York Software Industry Association, and was
appointed by Mayor Bloomberg to the New York City Workforce Investment Board.
Song attended Stevens Institute of Technology, where he majored in computer
science. Dino Ewing (Chief Financial Officer) Dino Ewing is the chief financial
officer at Reval where he is responsible for financial, human resource, and
administrative management as well as professional services. Prior to joining
Reval, he was the Chief Financial Officer of HealthFirst, Inc. and, prior to
that, Vice President of Operations. At HealthFirst, he was responsible for
financial management of a $200 million healthcare enterprise including: business
planning, financial reporting, and medical risk management. Before that, Ewing
worked as an investment banker at CS First Boston and as a strategy consultant
at Booz Allen & Hamilton, Inc. He also served as Director of Budget &
Analysis for the New York City Department of Transportation, overseeing the
city's $3 billion bridge rehabilitation program. He holds a bachelor's of arts
degree in economics, magna cum laude, from Yale University and an M.B.A. from
Stanford University. Philip Pettinato (Chief Operating Officer) Philip Pettinato
is responsible for the ongoing development and delivery of Reval's growing suite
of products and services. Pettinato has more than fifteen years of experience
managing and developing technology solutions for trading, risk management,
accounting and operational processing of capital markets products. He joined
Reval after seven years at EXIS Consulting, Inc., a leading financial software
provider of fixed income trading systems, where he headed product development,
operations and sales. Prior to that, he served in the global technology and
operations group at JP Morgan, where he led the development of mission-critical
systems for the government bond-trading desk. Pettinato holds a bachelor's of
science degree in computer science from Syracuse University and an M.B.A. with
honors from Baruch College's Zicklin School of Business. Jay McGlynn (Senior
Vice President , Sales) Jay McGlynn is the senior vice president of sales at
Reval where he is responsible for the growth of sales for North America, EMEA,
and APAC. McGlynn has over 35 years experience in sales leadership roles at both
large and early stage software companies. Most recently McGlynn was Senior Vice
President of Worldwide Sales at Parlano, a leading provider of enterprise group
messaging solutions, which was sold to Microsoft. Before Parlano, he was Vice
President of Worldwide Sales for Marketsoft. He also held similar posts at early
stage companies Fatwire and New Era of Networks. His background also includes
key sales roles at Wang, DEC and IBM. McGlynn holds a bachelor of science in
Business Administration from Villanova University. Vivian Shpigler (Chief
Marketing Officer) Vivian Shpigler is the chief marketing officer at Reval where
she is responsible for the global marketing and communications for the firm.
Shpigler has fourteen years of experience in senior financial services marketing
roles covering marketing strategy, integrated marketing communications,
branding, public relations and market research. Shpigler joined Reval from
Standard & Poor's where she held the roles of Director of Marketing
Optimization and Director of Marketing & Brand Management. Prior to Standard
& Poor's, she served as the Vice President of Marketing at Derivatech
leading to the company's acquisition by a division of SunGard. She also held
senior marketing roles at Market News International, Decalog and TheStreet.com.
Shpigler holds a bachelor's of science degree in management from Lehigh
University's College of Business and Economics. Justin Brimfield (Senior Vice
President, Business Development) Justin Brimfield is the Senior Vice President
of Business Development at Reval where he is responsible for guiding the firm
through the development of strategic alliances and business partnerships.
Brimfield brings with him a robust understanding of how Treasury professionals
can leverage SaaS technology to meet their growing needs and responsibilities.
Prior to joining Reval, Brimfield held a number of senior leadership roles at
Thomson Reuters for their suite of Treasury products and services since 2000
which included the building and management of their fixed income consulting
business. Over the years, Justin has worked directly with companies like General
Electric, Ford and Amazon.com, advising on how to effectively manage capital
markets transactions such as balance sheet restructuring, targeted bond
issuance, tender and exchange offerings and open market repurchases. Justin
graduated from the University of Rochester with B.A. degrees in Economics and
1 Şubat 2009 Pazar
Sistit, genellikle bir enfeksiyon sonucunda idrar kesesi (mesane)nin iltihaplanmasıdır .Prof.Dr.İbrahim Saraçoğlu Sistit için en faydalı ot...
Badminton , açık havanın olumsuz etkilerini önlemek amacıyla genellikle kapalı alanlarda oynanır. Kort 13.40 m uzunluğundadır. Genişlik tek...
SEZARYEN Eskiden sonuçları anne için tehlikelerle dolu olduğundan çok ender başvurulan sezaryen, günümüzde ameliyat ye uyuşturma teknikler...
Kına Kleopatra zamanından bu yana saç boyamakta başarıyla kullanılagelmiştir. Her ne kadar zamanımızda kimyasal boyalar moda olmuşsa da, bir...
Bazı kimseler beden yapıları açısından veya bazı psikolojik ve sosyal sebeplerle şehvet arzularının azalmasını isteyebilirler. Dinimiz...
2009 yazının en moda saçları nasıl olacak? 2009 yazında dağınık topuzları, örgülü saçları, uzun kakülleri, dalgaları ve bukleleri göreceğiz....
Rektal kanama genelde tuvalet kağında veya dışkıda parlak kırmızı renginde kan ile kendini belli eder. Büyük abdestinizdeki koyu kırmızı r...
uzunluk: minimum 90 maksimum 120 m genişlik : minimum 45 maksimum 90 m uluslarası maçlarda, uzunluk: minimum 45 maksimum 90 m genişlik : m...
Böbrek taşını harekete geçiren kimyasal güç avakado yaprağında bulunan "Methhychavicol" dur. Avakado yaprağını kaynatarak elde ede...
Teninize uygun parfüm olduğu gibi burcunuza görede parfümünüz olduğunu biliyormusunuz...İşte burcunuza uygun parfümler SU GRUBU (Yengeç,Bal...
Bu site yayınlanan sağlık ile ilgili bilgiler , ziyaretçilerini bilgilendirmek amacıyla yayınlanmaktadır. Burada yayınlanan yazıların tamamı bilgilendirme amaçlı olup, hiçbir şekilde hekim muayenesi ve konsültasyonunun yerine konulmamalı, hastalık ve diğer sorunlara yönelik teşhis ve tedavi amaçlı olarak kullanılmamalıdır. Sağlığınızla ilgili acil durumlarda, bekleme süresi sağlığınızı olumsuz yönde etkileyebileceği için, zaman geçirmeden bir sağlık kuruluşuna başvurmanızı öneririz.
Genel Kişisel Web
Genel Kişisel Web